Analysts Are Downgrading These 10 Pharmaceutical Stocks
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
Bicycle Therapeutics Plc (BCYC)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 1,855,993 | $81,441 | +69% | 5.22% |
| 2. | Point72 Asset Management Steve Cohen | 1,619,802 | $71,077 | +3% | 0.28% |
| 3. | Tybourne Capital Management Eashwar Krishnan | 1,154,126 | $50,643 | -44% | 2.99% |
| 4. | Logos Capital Arsani William | 950,000 | $41,686 | +10% | 5.4% |
| 5. | Great Point Partners Jeffrey Jay And David Kroin | 550,592 | $24,160 | +176% | 5.83% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.00 | 364,286 | Large Shareholder | 1,957,961 | 2019-05-28 | Filing | |
| $14.00 | 314,286 | Large Shareholder | 1,751,437 | 2019-05-29 | Filing | |
| $14.00 | 168,630 | Large Shareholder | 1,769,641 | 2019-05-28 | Filing | |
| $14.00 | 571,429 | Director | 571,429 | 2019-05-27 | Filing | |
| $14.00 | 7,983 | Large Shareholder | 39,637 | 2019-05-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $58.01 | 97,860 | Director | 0 | 2021-12-22 | Filing | |
| $57.11 | 44,537 | Director | 0 | 2021-12-21 | Filing | |
| $57.02 | 7,603 | Director | 0 | 2021-12-20 | Filing | |
| $60.00 | 49 | Officer, Director | 225,085 | 2021-10-18 | Filing | |
| $60.05 | 320 | Officer, Director | 225,134 | 2021-10-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 25,000 | $1,097,000 | 0.02% | |
| 2. | 1,692,774 | $74,297 | 0.03% | |
| 3. | 1,276,276 | $56,003 | 1.15% | |
| 4. | 1,263,471 | $55,441 | 0.86% | |
| 5. | 917,218 | $40,248 | 48.61% |
News See All
10 Healthcare Stocks to Buy Today According to Steven Cohen’s Point72 Asset Management
In this piece we will take a look at the 10 healthcare stocks to buy today according to Steven Cohen's Point72 Asset Management.
10 Small-Cap Stocks to Buy According to Billionaire Steve Cohen
In this article, we discuss the 10 small-cap stocks to buy according to billionaire Steve Cohen.
Analysts Just Increased Price Targets of These 10 Stocks
In this article, we discuss the 10 stocks that analysts just increased price targets of.
Is BCYC A Good Stock To Buy Now?
In this article we will analyze whether Bicycle Therapeutics plc (NASDAQ:BCYC) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas...
Hedge Funds Are Buying Bicycle Therapeutics plc (BCYC)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is Bicycle Therapeutics plc (BCYC) Going to Burn These Hedge Funds?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts, usually don't make them change their opinion towards ...
Billionaire Hedge Funds
